SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-247600
Filing Date
2017-08-03
Accepted
2017-08-03 17:15:01
Documents
72
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d417418d10q.htm 10-Q 563132
2 EX-31.1 d417418dex311.htm EX-31.1 8393
3 EX-31.2 d417418dex312.htm EX-31.2 8376
4 EX-32.1 d417418dex321.htm EX-32.1 4103
  Complete submission text file 0001193125-17-247600.txt   4034999

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cara-20170630.xml EX-101.INS 785438
6 XBRL TAXONOMY EXTENSION SCHEMA cara-20170630.xsd EX-101.SCH 44114
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cara-20170630_cal.xml EX-101.CAL 64007
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cara-20170630_def.xml EX-101.DEF 192997
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cara-20170630_lab.xml EX-101.LAB 377359
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cara-20170630_pre.xml EX-101.PRE 306065
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36279 | Film No.: 171006042
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences